The Gobeille decision is good for some organizations, but not the ones you may want to help

Nicholas has been all over the Gobeille v. Liberty Mutual case and decision, but, at STAT, Yevgeniy Feyman and I spin out one implication a bit further:

The Court’s blow to transparency doesn’t hurt everyone. Large, consolidated hospital systems, which usually provide higher-cost care, are the primary beneficiaries of price opacity. After all, if you’re the most expensive hospital in your market, why would you want that information made public?

We also explain how the decision is good for dominant insurers.

@afrakt

Share on twitter
Share on facebook
Share on linkedin
Share on reddit
Share on email

Hidden information below

Subscribe

* indicates required
Email Format